Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""van Santen HM"" wg kryterium: Autor


Tytuł:
BMI increase during early childhood in boys with cystic fibrosis and early adrenarche.
Autorzy:
Tamer G; Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center, Utrecht, the Netherlands.; Department of Pediatric Pulmonology, Wilhelmina Children's Hospital, University Medical Center, Utrecht, the Netherlands.
Arets HGM; Department of Pediatric Pulmonology, Wilhelmina Children's Hospital, University Medical Center, Utrecht, the Netherlands.
van der Ent CK; Department of Pediatric Pulmonology, Wilhelmina Children's Hospital, University Medical Center, Utrecht, the Netherlands.
van Santen HM; Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center, Utrecht, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
van der Kamp HJ; Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center, Utrecht, the Netherlands.
Pokaż więcej
Źródło:
Pediatric pulmonology [Pediatr Pulmonol] 2024 Jan 25. Date of Electronic Publication: 2024 Jan 25.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Could setmelanotide be the game-changer for acquired hypothalamic obesity?
Autorzy:
van Santen HM; Department of Pediatric Endocrinology, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Wilhelmina Children's Hospital, University Medical center Utrecht (UMCU), Utrecht, Netherlands.
Denzer C; Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany.
Müller HL; University Children's Hospital, Carl von Ossietzky University Oldenburg, Klinikum Oldenburg AöR, Oldenburg, Germany.
Pokaż więcej
Źródło:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2024 Jan 04; Vol. 14, pp. 1307889. Date of Electronic Publication: 2024 Jan 04 (Print Publication: 2023).
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Obesity, Morbid*/drug therapy
Hypothalamic Diseases*/complications
Hypothalamic Diseases*/drug therapy
Humans ; Child ; Prospective Studies ; Obesity/metabolism ; alpha-MSH/therapeutic use
Czasopismo naukowe
Tytuł:
The cumulative burden of self-reported, clinically relevant outcomes in long-term childhood cancer survivors and implications for survivorship care: A DCCSS LATER study.
Autorzy:
Streefkerk N; Department Pediatric Oncology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Teepen JC; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Feijen EAM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Jóźwiak K; Department of Epidemiology and Biostatistics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.
van der Pal HJH; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Ronckers CM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.
De Vries ACH; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology/Hematology, Sophia Children's Hospital/Erasmus Medical Center, Rotterdam, The Netherlands.
Van der Heiden-van Der Loo M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Hollema N; Department of Anesthesiology, Intensive Care and Pain Medicine, St. Antonius Hospital, Nieuwegein, The Netherlands.
van den Berg M; Department of Pediatric Oncology/Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Loonen J; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
Grootenhuis MA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Bresters D; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Versluys AB; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
van Dulmen-den Broeder E; Department of Pediatric Oncology/Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology/Hematology, Sophia Children's Hospital/Erasmus Medical Center, Rotterdam, The Netherlands.
van Leeuwen FE; Department of Epidemiology and Biostatistics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Neggers SJCMM; Medicine, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
Van Santen HM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Endocrinology, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, The Netherlands.
Hawkins M; Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
Hauptmann M; Department of Epidemiology and Biostatistics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.
Yoneoka D; Division of Biostatistics and Bioinformatics, Graduate School of Public Health, St. Luke's International University, Tokyo, Japan.
Korevaar JC; Netherlands Institute for Health Services Research, Utrecht, The Netherlands.
Tissing WJE; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology/Hematology, University of Groningen/University Medical Center Groningen, Groningen, The Netherlands.
Kremer LCM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, The Netherlands.; Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Pokaż więcej
Corporate Authors:
DCCSS LATER Study Group
Źródło:
Cancer [Cancer] 2023 Dec 15. Date of Electronic Publication: 2023 Dec 15.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Pediatric body composition based on automatic segmentation of computed tomography scans: a pilot study.
Autorzy:
Samim A; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht and Wilhelmina Children's Hospital, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. .; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. .
Spijkers S; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht and Wilhelmina Children's Hospital, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
Moeskops P; Quantib-U, Utrecht, The Netherlands.; Image Sciences Institute, University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands.
Littooij AS; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht and Wilhelmina Children's Hospital, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
de Jong PA; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht and Wilhelmina Children's Hospital, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
Veldhuis WB; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht and Wilhelmina Children's Hospital, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.; Quantib-U, Utrecht, The Netherlands.
de Vos BD; Quantib-U, Utrecht, The Netherlands.; Department of Biomedical Engineering and Physics, Amsterdam University Medical Centers - location AMC, Amsterdam, The Netherlands.
van Santen HM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.
Nievelstein RAJ; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht and Wilhelmina Children's Hospital, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Pokaż więcej
Źródło:
Pediatric radiology [Pediatr Radiol] 2023 Nov; Vol. 53 (12), pp. 2492-2501. Date of Electronic Publication: 2023 Aug 29.
Typ publikacji:
Journal Article
MeSH Terms:
Tomography, X-Ray Computed*/methods
Body Composition*
Male ; Female ; Humans ; Child ; Adolescent ; Pilot Projects ; Retrospective Studies ; Subcutaneous Fat
Czasopismo naukowe
Tytuł:
Tocilizumab for the fifth progression of cystic childhood craniopharyngioma-a case report.
Autorzy:
de Vos-Kerkhof E; Department of Neuro-oncology, Princess Máxima Center, Utrecht, Netherlands.
Buis DR; Department of Neurosurgery, University of Amsterdam, Amsterdam University Medical Center (UMC), Amsterdam, Netherlands.
Lequin MH; Department of Radiology, University Medical Center Utrecht, Utrecht, Netherlands.
Bennebroek CA; Department of Ophthalmology, Amsterdam University Medical Center (UMC), Amsterdam, Netherlands.
Aronica E; Department of Neuropathology, University of Amsterdam, Amsterdam University Medical Center (UMC), Amsterdam, Netherlands.
Hulleman E; Department of Neuro-oncology, Princess Máxima Center, Utrecht, Netherlands.
Zwaveling-Soonawala N; Department of Pediatric Endocrinology, Amsterdam University Medical Center (UMC), Amsterdam, Netherlands.
van Santen HM; Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands.
Schouten-van Meeteren AYN; Department of Neuro-oncology, Princess Máxima Center, Utrecht, Netherlands.
Pokaż więcej
Źródło:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2023 Oct 11; Vol. 14, pp. 1225734. Date of Electronic Publication: 2023 Oct 11 (Print Publication: 2023).
Typ publikacji:
Case Reports
MeSH Terms:
Craniopharyngioma*/complications
Craniopharyngioma*/drug therapy
Pituitary Neoplasms*/complications
Pituitary Neoplasms*/drug therapy
Pituitary Neoplasms*/pathology
Hypopituitarism*/pathology
Humans ; Female ; Child ; Adolescent ; Hypothalamus/pathology
Raport
Tytuł:
Acquired hypothalamic dysfunction in childhood: 'what do patients need?' - an Endo-ERN survey.
Autorzy:
van Roessel IMAA; Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.
de Graaf JP; Dutch Pituitary Foundation, Nijkerk, The Netherlands.; Department of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands.; Endo-ERN European Reference Network on Rare endocrine conditions.
Biermasz NR; Department of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands.; Endo-ERN European Reference Network on Rare endocrine conditions.
Charmandari E; Division of Endocrinology, Metabolism and Diabetes, First Department of Pediatrics, National and Kapodistrian University of Athens Medical School, Aghia Sophia Children's Hospital, Athens, Greece.; Division of Endocrinology and Metabolism, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
van Santen HM; Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.
Pokaż więcej
Źródło:
Endocrine connections [Endocr Connect] 2023 Sep 13; Vol. 12 (10). Date of Electronic Publication: 2023 Sep 13 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Elevated IGF-1 concentrations in children with low grade glioma: A descriptive analysis in a retrospective national cohort.
Autorzy:
van Schaik J; Division of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
van Roessel IMAA; Division of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Bos ID; Division of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.
Claashen-van der Grinten HL; Department of Pediatrics, Radboud University Medical Center, Amalia Children's Hospital, Nijmegen, The Netherlands.
Clement SC; Division of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Pediatrics, Emma Children's Hospital, Amsterdam University Medical Center, Amsterdam, The Netherlands.
van Iersel L; Division of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.
Bakker B; Division of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.
Meijer L; Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Kremer L; Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Schouten-van Meeteren AYN; Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
van Santen HM; Division of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Pokaż więcej
Źródło:
Journal of neuroendocrinology [J Neuroendocrinol] 2023 Aug; Vol. 35 (8), pp. e13317. Date of Electronic Publication: 2023 Jul 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Insulin-Like Growth Factor I*/metabolism
Glioma*/metabolism
Humans ; Child ; Retrospective Studies ; Prospective Studies ; Body Mass Index
Czasopismo naukowe
Tytuł:
Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design.
Autorzy:
van Hulst AM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands. Electronic address: .
van den Akker ELT; Erasmus MC, Sophia Children's Hospital, Wytemaweg 80, 3015 CN Rotterdam, the Netherlands.
Verwaaijen EJ; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.
Fiocco M; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands; Mathematical Institute, Leiden University, Rapenburg 70, 2311 EZ Leiden, the Netherlands; Department of Biomedical Data Science, section Medical Statistics, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA Leiden, the Netherlands.
Rensen N; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.
van Litsenburg RRL; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.
Pluijm SMF; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.
Zwaan CM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.
van Santen HM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands; Wilhelmina Children's Hospital, Lundlaan 6, 3584 EA Utrecht, the Netherlands.
Pieters R; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.
Evers AWM; Institute of Psychology, Rapenburg 70, 2311 EZ Leiden, the Netherlands.
Grootenhuis MA; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.
van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands; Wilhelmina Children's Hospital, Lundlaan 6, 3584 EA Utrecht, the Netherlands.
Pokaż więcej
Źródło:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Jul; Vol. 187, pp. 124-133. Date of Electronic Publication: 2023 Apr 07.
Typ publikacji:
Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Sleep Wake Disorders*/chemically induced
Sleep Wake Disorders*/prevention & control
Sleep Wake Disorders*/drug therapy
Male ; Humans ; Child ; Child, Preschool ; Adolescent ; Female ; Hydrocortisone/therapeutic use ; Cross-Over Studies ; Quality of Life ; Double-Blind Method ; Dexamethasone/therapeutic use
Czasopismo naukowe
Tytuł:
Clinical evaluation of late outcomes in Dutch childhood cancer survivors: Methodology of the DCCSS LATER 2 study.
Autorzy:
Feijen EAM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Teepen JC; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
van Dulmen-den Broeder E; Department of Pediatric Oncology/Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
van der Heiden-van der Loo M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
van der Pal HJH; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
de Vries ACH; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology/Hematology, Erasmus Medical Center, Rotterdam, The Netherlands.
Louwerens M; Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands.
Bresters D; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Versluys B; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
de Ridder H; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Veening M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
van Leeuwen FE; Department of Epidemiology and Biostatistics, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Grootenhuis M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Maurice-Stam H; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
van Santen HM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Endocrinology, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, The Netherlands.
Neggers SJCMM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Medicine, Endocrinology Section, Pituitary Center Rotterdam, Erasmus University Medical Center, Rotterdam, The Netherlands.
Pluijm S; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
den Hartogh J; Department VOX Survivors, Dutch Childhood Cancer Parent Organization VOKK Netherlands, Nieuwegein, The Netherlands.
Ronckers CM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Brandenburg Medical School, Institute of Biostatistics and Registry Research, Neuruppin, Germany.
Tissing WJE; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Loonen JJ; Radboudumc Center of Expertise for Cancer Survivorship, Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
Kremer LCM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, The Netherlands.; Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
Pediatric blood & cancer [Pediatr Blood Cancer] 2023 May; Vol. 70 (5), pp. e30212. Date of Electronic Publication: 2023 Jan 18.
Typ publikacji:
Journal Article
MeSH Terms:
Cancer Survivors*
Neoplasms*/therapy
Neoplasms*/epidemiology
Male ; Child ; Humans ; Female ; Adolescent ; Young Adult ; Adult ; Middle Aged ; Aged ; Quality of Life ; Cross-Sectional Studies ; Outcome Assessment, Health Care
Czasopismo naukowe
Tytuł:
Decreased breadth of the antibody response to the spike protein of SARS-CoV-2 after repeated vaccination.
Autorzy:
Horndler L; Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid, Madrid, Spain.
Delgado P; Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid, Madrid, Spain.
Romero-Pinedo S; VITRO SA, Granada, Spain.
Quesada M; VITRO SA, Granada, Spain.
Balabanov I; Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid, Madrid, Spain.
Laguna-Goya R; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.
Almendro-Vázquez P; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.
Llamas MA; Empíreo Diagnóstico Molecular, Madrid, Spain.
Fresno M; Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid, Madrid, Spain.
Paz-Artal E; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; Department of Immunology, Ophthalmology and ENT, Universidad Complutense de Madrid, Madrid, Spain.
van Santen HM; Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid, Madrid, Spain.
Álvarez-Fernández S; VITRO SA, Granada, Spain.
Olmo A; VITRO SA, Granada, Spain.
Alarcón B; Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid, Madrid, Spain.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Apr 03; Vol. 14, pp. 1157263. Date of Electronic Publication: 2023 Apr 03 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
SARS-CoV-2*
COVID-19*/prevention & control
Humans ; Antibody Formation ; BNT162 Vaccine ; COVID-19 Vaccines ; ChAdOx1 nCoV-19 ; Spike Glycoprotein, Coronavirus ; Vaccination ; Antibodies
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł:
Thyroid dysfunction during treatment with systemic antineoplastic therapy for childhood cancer: A systematic review.
Autorzy:
van der Leij S; Department of Endocrinology, University Medical Center, Utrecht, the Netherlands; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Electronic address: .
Lebbink CA; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: .
Lentjes EG; Laboratory Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: .
Tissing WJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Oncology, Beatrix Children's Hospital, University Medical Center Groningen, the Netherlands. Electronic address: .
Stuart AV; Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: .
van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Electronic address: .
van Santen HM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: .
van Dalen EC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Electronic address: .
Pokaż więcej
Źródło:
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2023 Apr; Vol. 184, pp. 103958. Date of Electronic Publication: 2023 Mar 11.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
Neoplasms*/complications
Neoplasms*/drug therapy
Antineoplastic Agents*/adverse effects
Thyroid Diseases*/chemically induced
Thyroid Diseases*/epidemiology
Adult ; Child ; Humans ; Prospective Studies
Czasopismo naukowe
Tytuł:
Frailty and sarcopenia within the earliest national Dutch childhood cancer survivor cohort (DCCSS-LATER): a cross-sectional study.
Autorzy:
van Atteveld JE; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands. Electronic address: .
de Winter DTC; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
Pluimakers VG; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
Fiocco M; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Medical Statistics Section, Department of Biomedical Data Science, Leiden University Medical Center, Leiden, Netherlands; Mathematical Institute, Leiden University, Leiden, Netherlands.
Nievelstein RAJ; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, Netherlands.
Hobbelink MGG; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, Netherlands.
Kremer LCM; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands; Emma Children's Hospital, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands.
Grootenhuis MA; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
Maurice-Stam H; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
Tissing WJE; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Department of Pediatric Oncology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
de Vries ACH; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Department of Pediatric Oncology, Sophia Children's Hospital, Erasmus Medical Center, Rotterdam, Netherlands.
Loonen JJ; Department of Hematology, Radboud University Medical Center, Nijmegen, Netherlands.
van Dulmen-den Broeder E; Department of Pediatric Oncology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands.
van der Pal HJH; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
Pluijm SMF; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
van der Heiden-van der Loo M; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Dutch Childhood Oncology Group, Utrecht, Netherlands.
Versluijs AB; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
Louwerens M; Department of Internal Medicine, Leiden University Medical Center, Leiden, Netherlands.
Bresters D; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Department of Pediatrics, Willem Alexander Children's Hospital, Leiden University Medical Center, Leiden, Netherlands.
van Santen HM; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Department of Pediatric Endocrinology, University Medical Center Utrecht, Utrecht, Netherlands.
Hoefer I; Central Diagnostic Laboratory, University Medical Center Utrecht, Utrecht, Netherlands.
van den Berg SAA; Department of Clinical Chemistry, Erasmus Medical Center, Rotterdam, Netherlands; Department of Internal Medicine, Section Endocrinology, Erasmus Medical Center, Rotterdam, Netherlands.
den Hartogh J; Dutch Childhood Cancer Organisation, De Bilt, Netherlands.
Hoeijmakers JHJ; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Oncode Institute and Department of Molecular Genetics, Erasmus Medical Center, Rotterdam, Netherlands.
Neggers SJCMM; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Department of Internal Medicine, Section Endocrinology, Erasmus Medical Center, Rotterdam, Netherlands.
van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands.
Pokaż więcej
Corporate Authors:
Dutch LATER study group
Źródło:
The lancet. Healthy longevity [Lancet Healthy Longev] 2023 Apr; Vol. 4 (4), pp. e155-e165.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cancer Survivors*
Sarcopenia*/diagnosis
Sarcopenia*/epidemiology
Sarcopenia*/etiology
Frailty*/epidemiology
Frailty*/chemically induced
Folic Acid Deficiency*/chemically induced
Neoplasms*/complications
Neoplasms*/epidemiology
Hyperthyroidism*/chemically induced
Male ; Female ; Humans ; Cisplatin/adverse effects ; Cross-Sectional Studies ; Thinness/chemically induced ; Growth Hormone
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies